Study Evaluating PPM-204 In Subjects With Type 2 Diabetes
NCT00425919 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 500
Last updated 2007-12-27
Summary
The purpose of this study is to learn whether PPM-204 has an effect on lowering blood glucose (blood sugar) levels and is safe in treating people with type 2 diabetes.
Conditions
Interventions
- DRUG
-
PPM-204
Sponsors & Collaborators
-
Wyeth is now a wholly owned subsidiary of Pfizer
lead INDUSTRY
Principal Investigators
-
Medical Monitor · Wyeth is now a wholly owned subsidiary of Pfizer
-
Trial Manager · For Argentina, [email protected]
-
Trial Manager · For Australia, [email protected]
-
Trial Manager · For Brazil, [email protected]
-
Trial Manager · For Austria, [email protected]
-
Trial Manager · For Canada, [email protected]
-
Trial Manager · For Chile, [email protected]
-
Trial Manager · For China, [email protected]
-
Trial Manager · For Croatia, [email protected]
-
Trial Manager · For Greece, [email protected]
-
Trial Manager · For Hong Kong, [email protected]
-
Trial Manager · For Italy, [email protected]
-
Trial Manager · For Mexico, [email protected]
-
Trial Manager · For Romania, [email protected]
-
Trial Manager · For Russia, [email protected]
-
Trial Manager · For Serbia, [email protected]
-
Trial Manager · For South Africa, [email protected]
-
Trial Manager · For UK/Great Britian, [email protected]
-
Trial Manager · For Ukraine, [email protected]
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2007-01-31
- Completion
- 2007-10-31
Countries
- United States
- Argentina
- Australia
- Brazil
- Canada
- China
- Croatia
- Greece
- Hong Kong
- India
- Italy
- Mexico
- Romania
- Russia
- Serbia and Montenegro
- South Africa
- Ukraine
- United Kingdom
Study Locations
More Related Trials
-
Study Evaluating Multiple Oral Doses of PPM-204 in Healthy Japanese Male Subjects
NCT00448032 ·Status: COMPLETED ·Phase: PHASE1
-
A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus
NCT01792635 ·Status: TERMINATED ·Phase: PHASE2
-
A Multiple Dose Study Of PF-04620110 In Type 2 Diabetes Patients
NCT01298518 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety and Efficacy of TTP054 for 12 Weeks in Subjects With Type 2 Diabetes
NCT01665352 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Of PF-05190457 In Healthy Volunteers And Type-2 Diabetic Patients
NCT01372163 ·Status: TERMINATED ·Phase: PHASE1
-
PF-06291874 Multiple Ascending Dose Study In Type 2 Diabetes Mellitus Patients
NCT01856595 ·Status: COMPLETED ·Phase: PHASE1
-
Study In People With Type 2 Diabetes
NCT00196989 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Trial to Study the Efficacy, Safety, Tolerability and Pharmacokinetics of P2202 in Patients of Type 2 Diabetes
NCT01674348 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus
NCT02211261 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Tolerability of Ascending Intravenous Doses of PF-05231023 In Adult Subjects With Type 2 Diabetes
NCT01396187 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone
NCT00970424 ·Status: TERMINATED ·Phase: PHASE3
-
Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Study Of PF-06291874 As Oral Monotherapy To Treat Adults With Type 2 Diabetes Mellitus
NCT02175121 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Dipeptidyl-peptidase IV (DPP-IV) RO4876904 in Patients With Type 2 Diabetes.
NCT00502710 ·Status: COMPLETED ·Phase: PHASE2
-
A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus
NCT03985293 ·Status: COMPLETED ·Phase: PHASE2
-
Dose-finding of PB-119 Administered Subcutaneously Once-weekly Versus Placebo in Drug-naïve T2DM Subjects
NCT03520972 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Ro 205-2349 in Patients With Type 2 Diabetes Mellitus
NCT00057317 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Control Via Metformin Hydrochloride Monotherapy
NCT05326490 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy
NCT01240759 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus
NCT05158244 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy and Safety of PAZ320 on PPG and Insulin Blood Levels in Type II Diabetic Patients
NCT04569214 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
NCT00039013 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy
NCT04504396 ·Status: COMPLETED ·Phase: PHASE3
-
A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes
NCT01469065 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety and Efficacy of MK8245 in Patients With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK8245-005 AM2)
NCT00846391 ·Status: TERMINATED ·Phase: PHASE2
-
Safety And Tolerability Of Escalating Intravenous Doses Of PF-05231023 In Adult Subjects With Type 2 Diabetes
NCT01285518 ·Status: COMPLETED ·Phase: PHASE1